About the malaria vaccine roadmap
Global strategy aims to accelerate vaccine development
The world’s leading international health organizations have developed a global strategy for accelerating the development and licensing of a highly effective malaria vaccine.
The plan is known as the Malaria Vaccine Technology Roadmap. It calls for the malaria vaccine community—scientists, funding organizations, policy experts, and national and global decision-makers—to develop an effective vaccine that prevents severe disease and death caused by Plasmodium falciparum, the most deadly form of the malaria parasite. The roadmap outlines a path toward:
- Developing and licensing a first-generation vaccine by 2015 with 50 percent protective efficacy against severe disease and death that would last longer than one year.
- Developing a malaria vaccine by 2025 that would have a protective efficacy of more than 80 percent against clinical disease and that would provide protection for longer than four years.
Click to download a full copy of the Malaria Vaccine Technology Roadmap (1.91 MB PDF).
The roadmap is currently being reviewed and updated. Read more about this process on WHO's website.